Asal Shirazi, Founder and CEO of the Autoimmune Support and Awareness (ASA) Foundation, explains the challenges in detecting, diagnosing and managing autoimmune conditions.
Rhett Reichard, PhD and Keri C. Smith, PhD from Saba University School of Medicine, says that while multiple sclerosis is a debilitating disease, new treatments offer hope.
The immune system is the body’s natural defence against antigens such as bacteria and viruses, but in some cases, it can malfunction. We explore the prevalence of immune system disorders, the associated unmet medical needs, and therapeutic research.
The number of people contracting autoimmune diorders in the United Kingdom is growing, including diseases like type 1 diabetes and rheumatoid arthritis. But why?
Dr. Ludivine Herman, Project Leader at immunotherapy specialist Imcyse, walks us through Neuoromyelitis optica facts & trends, the challenges of current therapies and the potential of immunotherapies.
Phillip Anderson, Head of Policy at the MS Society UK, describes the need to improve multiple sclerosis treatment, care & support, including access to disease modifying therapies.
Pascale V Guillot, Associate Professor at University College London, investigates the possibility of exosome therapy for those living with brittle bone disease.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the main focus of non-melanoma skin cancer, including its steadily rising incidence in the UK.